Resources from the same session
Presidential Symposium 3 - Invited discussant
Presenter: Tony S.K. Mok
Session: Presidential Symposium 3
Resources:
Slides
Webcast
Presidential Symposium 3 - Invited discussant
Presenter: Jean-Pascal Machiels
Session: Presidential Symposium 3
Resources:
Slides
Webcast
4832 - KEYNOTE-048: Phase 3 study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Presenter: Barbara Burtness
Session: Presidential Symposium 3
Resources:
Abstract
Slides
Webcast
6660 - Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy
Presenter: Hisham Mehanna
Session: Presidential Symposium 3
Resources:
Abstract
Slides
Webcast
4092 - Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC
Presenter: Caicun Zhou
Session: Presidential Symposium 3
Resources:
Abstract
Slides
Webcast